Monica B. Norton

Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 Inhibitors

David B. Reitz, James J. Li, Monica B. Norton et al. · Journal of Medicinal Chemistry · 1994 · 118 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Pre-clinical Pharmacology +19

Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents

James J. Li, Monica B. Norton, Emily J. Reinhard et al. · Journal of Medicinal Chemistry · 1996 · 106 citations · Full text

Terphenyl Methyl Sulfones, Pharmaceutical Science, Pharmacotherapy +17

Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer Protein

Emily J. Reinhard, Jane L. Wang, Richard C. Durley et al. · Journal of Medicinal Chemistry · 2003 · 48 citations · Full text

Lower Potency, Medicinal Chemistry, Oxysterol +13

N1-sterically hindered 2H-imidazol-2-one angiotensin II receptor antagonists: The conversion of surmountable antagonists to insurmountable antagonists

David B. Reitz, Danny J. Garland, Monica B. Norton et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 21 citations

Surmountable Antagonists, Medicine, Physiology +6

Novel 1,2-diarylcyclopentenes are selective, potent, and orally active cyclooxygenase inhibitors

David B. Reitz, James J. Li, Monica B. Norton et al. · Medicinal Chemistry Research · 1995 · 13 citations

Medicinal Chemistry, Biochemistry, Medicine +10